Table 1 Information of articles
Rows | Name [references] | Country | Year of publication | Participants | Prevalence |
|---|---|---|---|---|---|
1 | Seung Hoon Lee [34] | South Korea | 2017 | 654 | Germ cell tumors (pituitary adenomas: 6.7%, pineal tumor: 34.5%, Brain tumor: 35%) |
2 | Yeon-Lim Suh [25] | Korea | 2002 | 3221 | Pituitary adenomas: 19%, meningioma: 24%, tumors of neuroepithelial tissue: 31.6%(embryonal tumors: 2.6% MEDULLOBLASTOMA: 1.8%, ependymal tumors: 1.8%, glial tumor of CNS and pineal gland: 2.3%, astrocytic tumors of CNS: 8.9%, oligodendroglial: 3.3%, choroid plexus: 0.4%, glioblastoma: 10.6%), germ cell tumors: 1.7% |
3 | Yeon-Lim Suh [25] | Korea | 2002 | 2556 | Pituitary adenomas: 15.1%, meningioma: 25.1%, tumors of neuroepithelial tissue: 34.9%(glioblastoma: 4.8%, glial tumor of CNS and pineal gland: 0.35%, astrocytic tumors of CNS: 15.9%, oligodendroglial: 4.6%, choroid plexus: 0.4%, embryonal tumors: 3.3%, ependymal tumors: 2.4%) germ cell tumors: 1.7% |
4 | Anirban Ghosh [42] | India | 2004 | 873 | Brain tumor [glioma: 60% (ependymal tumors: 3.2%, astrocytic tumors of CNS: 36.7%, oligodendroglial: 4.9%), meningioma: 11.6%, pineal tumor: 0.2%, medulloblastoma: 1.6%, pituitary adenomas: 4.1%] |
5 | Axel Tjo¨ rnstrand [43] | Sweden | 2014 | 592 | Pituitary adenomas: 100% |
6 | Adrian F. Daly [44] | Belgium | 2006 | 68 | Pituitary adenomas: 100% |
7 | Kullapat Veerasarn [45] | Thailand | 2016 | 93,810 | Pituitary adenomas: 3.8%, meningioma: 15.3%, pineal tumor: 1.9% |
8 | Kurupath Radhakrishnan [46] | USA | 1995 | 339 | Pituitary adenomas: 16.2%, glioma: 29.4% (ependymal tumors: 1.1%, astrocytic tumors of CNS: 24.7%, oligodendroglial: 3.2%), meningioma: 40.1%, schwannoma: 4.4%, medulloblastoma: 1.7% |
9 | T.B. Johannesen [36] | Norway | 2004 | 14,641 | Pituitary adenomas: 9.3%, meningioma: 21.9%, pineal tumor: 0.7%, brain tumor: 60.1%, spinal tumor: 1.9% |
10 | Yun-Sik Dho [41] | Republic of Korea | 2017 | 11,827 | 10 pituitary adenomas: 17.9%, meningioma: 37.2%, tumors of neuroepithelial tissue: 13.6% (glioma: 12.6%, ependymal tumors: 0.9%, glial tumor of CNS and pineal gland: 1.07%, astrocytic tumors of CNS: 2.03%, oligodendroglial: 1.2%, choroid plexus: 0.16, glioblastoma: 5.3%, pilocytic astrocytomas : 0.4%), germ cell tumors: 1.07% |
11 | Ahmad F. Tamimi [47] | Jordan | 2015 | 313 | Pituitary adenomas: 9.2%, embryonal tumors: 7.02 (medulloblastoma: 4.7%), meningioma: 26.1%, tumors of neuroepithelial tissue: 37.6 (ependymal tumors: 1.5%, astrocytic tumors of CNS: 9.2%, oligodendroglial: 1.2%, choroid plexus: 0.3%, glioblastoma: 18.8%, pilocytic astrocytomas: 3.8%), schwannoma: 3.8% |
12 | Leonard T. Kurland [48] | USA | 1982 | 223 | Pituitary adenomas: 13%, glioma: 34.9%, meningioma: 39.4% |
13 | Leonard T. Kurland [48] | USA | 1982 | 189 | Pituitary adenomas: 12.1%, glioma: 35.9%, meningioma: 39.6% |
14 | Chang-Hyun Lee [2] | Korea | 2010 | 5,692 | Pituitary adenomas: 13.8, meningioma: 29.6%, tumors of neuroepithelial tissue: 19.3% (glioma: 1.9%, embryonal/primitive /medulloblastoma: 1.2%, ependymal tumors: 1.1%, glioblastoma: 5.9%, astrocytic tumors of CNS: 4.8%, oligodendroglial: 1.05%, choroid plexus: 0.26%) |
15 | Haley Gittleman [16] | USA | 2014 | 51,125 | Pituitary adenomas: 100% |
16 | NUNG WON CHOI [49] | USA | 1970 | 760 | Pituitary adenomas: 2.6%, glioma: 56.7% (ependymal tumors: 2.8%, astrocytic tumors of CNS: 17.5%, Oligodendroglial: 1.3%, glioblastoma: 20.9%, medulloblastoma: 2.5%), meningioma: 6.8% |
17 | David Gigineishvili [21] | Georgia | 2013 | 980 | Pituitary adenomas: 11.7%, meningioma: 25.9%, tumors of neuroepithelial tissue: 13.1% (glioblastoma: 4.8%, ependymal tumors: 0.4%, astrocytic tumors of CNS: 3.3%, oligodendroglial: 1.22%) |
18 | D.Gigineishvili [50] | Georgia | 2013 | 473 | Pituitary adenomas: 17.9%, meningioma: 45.2%, glioblastoma: 9.9% |
19 | Ramandeep S. Arora [51] | England | 2009 | 54,336 | Pituitary adenomas: 8.8%, meningioma: 15.8%, pineal tumor: 0.38%, tumors of neuroepithelial tissue: 53% (embryonal tumors: 1.5% (medulloblastoma: 1.07%), ependymal tumors: 1.96%, astrocytic tumors of CNS: 35.2% (glioblastoma: 21.7%, pilocytic astrocytomas: 1.68%), oligodendroglial: 12.2%, choroid plexus: 0.18%), tumors of cranial and spinal nerves: 6.8% |
20 | Alberto Fernandez [52] | England | 2010 | 63 | Pituitary adenomas: 100% |
21 | Giuseppe D 'Alessandro [53] | Italy | 1995 | 178 | Pituitary adenomas: 14%, meningioma: 37%, tumors of neuroepithelial tissue: 34.8% |
22 | Amélie Darlix [54] | France | 2017 | 57,816 | Pituitary adenomas: 3.7%, meningioma: 7.1%, tumors of neuroepithelial tissue: 43.5% (glioma: 39.1%, embryonal tumors: 1.6% (medulloblastoma: 0.95%), ependymal tumors: 2.3%, astrocytic tumors of CNS: 26.5% (glioblastoma: 21.4%), oligodendroglial: 5.9%, choroid plexus: 0.3%), germ cell tumors: 0.4%, schwannoma: 8.6% |
23 | Hideo Nakamura [39] | Japan | 2011 | 5,448 | Pituitary adenomas: 17.8%, glioma: 19.5%, meningioma: 36.7%, schwannoma: 9.9%, medulloblastoma: 0.45% |
24 | Dale L. Preston [37] | Japan | 2002 | 467 | Pituitary adenomas: 7.49%, glioma: 9.2%, meningioma: 18.8%, schwannoma: 11.3% |
25 | Charles A. Stiller [17] | Great Britain (England, Scotland and Wales) | 2019 | 4166 | Pituitary adenomas: 1.6%, embryonal tumors: 2.6%, ependymal tumors: 6.98%, meningioma: 1.2%, pineal tumor: 1.1%, astrocytic tumors of CNS: 40.9% (glioblastoma: 3.5%, pilocytic astrocytomas: 20.6%) oligodendroglial: 0.8%, choroid plexus: 2.6%, germ cell tumors: 4%, atypical teratoid/rhabdoid tumors: 1.94%, medulloblastoma: 12.5% |
26 | Tanya S. Surawicz [55] | USA | 1999 | 20,765 | Pituitary adenomas: 8%, meningioma: 25.3%, tumors of neuroepithelial tissue: 51.2% (glioma: 3.6%, embryonal tumors: 1.8%, ependymal tumors: 2.36%, glial tumor of CNS and pineal gland: 1.2%, astrocytic tumors of CNS: 8.1%, oligodendroglial: 2.6%, choroid plexus: 0.3%, glioblastoma: 22.6%, medulloblastoma: 1.8%, pilocytic astrocytomas: 1.78%), spinal tumor and tumors of cranial nerves: 6.5% |
27 | Emily A.J. Sehmer [19] | England | 2014 | 435 | Glioma (astrocytic tumors of CNS: 9.6% (glioblastoma: 86.4%), oligodendroglial: 0.4%) |
28 | Luc Bauchet [20] | France | 2009 | 1017 | Glioma: 51.7% (astrocytic tumors of CNS: 32.3% (glioblastoma: 2.3%, pilocytic astrocytomas: 23.1%), oligodendroglial: 6.5%, ependymal tumors: 8.4%), embryonal tumors: 19% (medulloblastoma: 14.9, atypical teratoid/rhabdoid tumors: 1.08%), glioneuronal tumor: 8.3%, meningioma: 2.3%, pineal gland: 1.08%, choroid plexus: 2.8%, germ cell tumors: 3.5%, Schwannoma: 2.3 |
29 | David J. Cote [56] | USA | 2019 | 97,810 | Glioma (ependymal tumors: 6.7%, nonglioblastoma astrocytomas: 20.4, oligodendroglial: 8%, glioblastoma: 57.4%) |
30 | S Preston-Martin [57] | USA | 1989 | 8612 | Glioma: 50.1% (ependymal tumors: 1.3%, astrocytic tumors of CNS: 23.1%, oligodendroglial: 1.5%, glioblastoma: 18.2%, medulloblastoma: 2.2%), meningioma: 28% |
31 | K. Gousias [58] | Greece | 2009 | 56 | Glioma: 100% |
32 | Faith G. Davis [32] | USA | 2001 | 6908 | Glioma: 3.5%, embryonal tumors: 1.4%, ependymal tumors: 1.3%, meningioma: 26.5%, astrocytic tumors of CNS: 6.3%, oligodendroglial: 1.7%, glioblastoma: 22.3%, pilocytic astrocytomas: 1.3% |
33 | Yoshikazu Okamoto [59] | Switzerland | 2004 | 122 | Glioma (oligodendroglial: 40.9%) |
34 | Emmanuel Desandes [33] | France | 2014 | 3886 | Glioma: 6.7%, ependymal tumors: 6.4%, meningioma: 1.5%, oligodendroglial: 4.1%, choroid plexus: 2.7%, glioblastoma: 1.6%, germ cell tumors: 5.6%, atypical teratoid/rhabdoid tumors: 2.4%, medulloblastoma: 13.7%, pilocytic astrocytomas: 21.8% |
35 | Kenneth R. Hess [60] | USA | 2004 | 22,427 | Glioma: 2.8%, astrocytic tumors of CNS: 36.6%, oligodendroglial: 6.04%, glioblastoma: 52.02 |
36 | M. P. W. A. Houben [61] | the Netherlands | 2006 | 11,812 | Glioma: (ependymal tumors: 3.2%, oligodendroglial/mixed glioma: 11.8%) |
37 | Helle Collatz Christensen [18] | DENMARK | 2003 | 11,935 | Glioma: 100% (meningioma: 40.59) |
38 | Janhvi Jaiswal [27] | India | 2016 | 4295 | Glioma: 34.1%, ependymal tumors: 2.2%, astrocytic tumors of CNS: 3.1%, oligodendroglial: 9.5%, glioblastoma: 12.9%, pilocytic astrocytomas: 2.07% |
39 | Faith G. Davis [62] | USA | 1996 | 8,070 | Glioma: 5.3%, ependymal tumors: 1.6%, meningioma: 21.1%, pineal tumor: 0.16%, astrocytic tumors of CNS: 19.7%, oligodendroglial: 2.1%, glioblastoma: 25.4%, medulloblastoma: 1.8%, pilocytic astrocytomas: 1.5% |
40 | Tola MR [63] | Italy | 1994 | 169 | Glioma (ependymal tumors: 1.7%, astrocytic tumors of cns: 16.5%, oligodendroglial: 7.6%, glioblastoma: 48.5%) |
41 | Camille Pouchieu [29] | France | 2018 | 3515 | Meningioma: 37.5%, tumors of neuroepithelial tissue: 42.5% (glioma: 4.03%, ependymal tumors: 1.9%, pineal tumor: 0.08%, astrocytic tumors of CNS: 4.2%, oligodendroglial: 0.79%, choroid plexus: 0.28%, glioblastoma: 26.8%, pilocytic astrocytomas: 0.96%), germ cell tumors and cysts: 0.5%, cranial and spinal nerve tumors: 12%, |
42 | Kimberly R. Porter [64] | USA | 2010 | 18 037 | Glioma: 33.2%, meningioma: 32.8% |
43 | Susan preston-martin [65] | USA | 1990 | 462 | Glioma: 28.3%, ependymal tumors: 15.1%, meningioma: 42.8%, astrocytic tumors of CNS: 11.25% |
44 | Adele Caldarella [30] | Italy | 2011 | 4,417 | Embryonal tumors: 0.7%, ependymal tumors: 0.9%, meningioma: 27.8%, pineal tumor: 0.02%, astrocytic tumors of CNS: 25.3%, oligodendroglial: 1.3%, choroid plexus: 0.02%, germ cell tumors: 0.02% |
45 | Rafael Fuentes-Raspall [66] | Spain | 2011 | 679 | Embryonal tumors: 3.5%, ependymal tumors: 1.9%, Astrocytic tumors of CNS: 35.7%, oligodendroglial tumors and mixed histologies: 2.5%, choroid plexus: 0.14% |
46 | Sarah Khan [67] | United Arab Emirates | 2020 | 744 | Embryonal tumors: 13.03%, ependymal tumors: 6.18%, meningioma: 4.1%, astrocytic tumors of CNS: 69.6%(diffuse astrocytic and oligodendroglial tumors: 64.9%), choroid plexus: 0.5%, germ cell tumors: 1.7% |
47 | Emanuele Crocetti [26] | Austria, Iceland, Ireland, Malta, Norway, Slovakia, Slovenia, Sweden, Northern Ireland, Scotland and Wales and Other 10 countries | 2012 | 44,947 | Embryonal tumors: 4.1%, ependymal tumors: 3.59%, astrocytic tumors of CNS: 85.9%, oligodendroglial: 6.4%, choroid plexus: 0.1% |
48 | Gillian C. Cole [68] | Wales | 1989 | 526 | Ependymal tumors: 4.7%, pineal tumor: 0.9%, astrocytic tumors of CNS: 52.6%, oligodendroglial: 6.8%, germ cell tumors: 0.7%, medulloblastoma: 1.7% |
49 | Kate A. Schellinger [22] | USA | 2008 | 3,226 | Spinal tumor: 69.9% (ependymal tumors: 23%, meningioma: 29%) |
50 | Linh M. Duong [69] | USA | 2012 | 11,712 | Ependymal tumors: 21.1%, meningioma: 32.6%, spinal tumor: 26.6%, pilocytic astrocytomas: 1.6% |
51 | Naseem Ahmed [70] | Pakistan | 2007 | 81 | Ependymal tumors: 9.8%, astrocytic tumors of CNS: 35.8%, oligodendroglial: 1.2%, glioblastoma multiforme: 3.7%, pilocytic astrocytomas: 14.8% |
52 | Peter Kaatsch [24] | Germany | 2001 | 3268 | Ependymal tumors: 10.3%, meningioma: 1.16%, pineal tumor: 1.3%, astrocytic tumors of CNS: 41.7% |
53 | Therese A. Dolecek [23] | USA | 2015 | 51,065 | Meningioma: 100% |
54 | Bernd Holleczek [71] | Germany | 2019 | 992 | Meningioma: 100% |
55 | S. Zouaoui [72] | France | 2018 | 13,038 | Meningioma: 100% |
56 | Luis Eduardo Werneck de Carvalho [73] | Brazil | 2017 | 949 | Meningioma: 24.9%, tumors of neuroepithelial tissue: 40%, germ cell tumors: 0.9% |
57 | Mousa Taghipour [74] | Iran | 2010 | 371 | Meningioma: 100% |
58 | Lars Klaeboe [75] | Denmark, Finland, Norway and Sweden | 2005 | 18,630 | Meningioma: 100% |
59 | Lona C [31] | Italy | 1988 | 182 | Meningioma: 28.5%, tumors of neuroepithelial tissue: 56.04%, germ cell tumors: 1.09% |
60 | CHRISTOPH BURKHARD [40] | Switzerland | 2003 | 196 | Pilocytic astrocytomas: 28% |
61 | Keishi Makino [76] | Japan | 2013 | 6,615 | Pineal tumor: 0.46%, germ cell tumors: 1.05% |
62 | Donna L. Johnston [77] | Canada | 2014 | 574 | Medulloblastoma: 100% |
63 | Yousef S. Khader [35] | Jordan | 2018 | 2096 | Brain tumor: 100% |
64 | Maria Teresa GIORDANA [78] | Italy | 1999 | 45 | Medulloblastoma: 68.8% |
65 | JIANG Tao [79] | China | 2011 | 636 | Brain tumor: 100% |
66 | S. Cordera [80] | Italy | 2002 | 253 | Tumors of neuroepithelial tissue: 35.1% |
67 | Adalberto Miranda-Filho [81] | Brazil, France | 2017 | 78,034 | Primary CNS tumors: 100% |
68 | Sandrine Elia-Pasquet [82] | France | 2004 | 329 | Brain tumor: 92.4%, spinal tumor: 7.5% |
69 | Birthe Krogh Rasmussen [83] | Denmark | 2017 | 1930 | Astrocytic tumors of CNS: 15.5%, oligodendroglial: 5.9%, glioblastoma: 70.6%, pilocytic astrocytomas: 1.8% |
70 | Hyeon Jin Park [84] | Korea | 2016 | 2,116 | Germ cell tumors: 54.3% |
71 | Rose Lai [85] | USA | 2008 | 454 | Medulloblastoma: 100% |
72 | Agne` s Fleury [86] | France | 1997 | 1376 | Astrocytic tumors of CNS: 68.3% |
73 | Abbas Rezaianzadeh [87] | Iran | 2020 | 1043 | Brain tumor: 100% |
74 | Malene Schjønning Nielsen [28] | Denmark | 2009 | 1,304 | Oligodendroglial: 100% |
75 | Marios K. Georgakis [88] | 12 SEE countries (Belarus, Croatia, Cyprus, Malta, Montenegro, Greater Poland, Portugal Central, Portugal North, Romania-Cluj, Romania-Iasi, Serbia Central, Slovenia, Turkey-Izmir and Ukraine) | 2017 | 11,438 | Primary CNS tumors: 100% |
76 | Nicolas R. Smoll [38] | Australia | 2012 | 1372 | Medulloblastoma: 100% |
77 | ARE HELSETH [89] | Norway | 1995 | 10,936 | Primary CNS tumors: 100% |
78 | Stefan L¨ONN [90] | Denmark, Finland, Norway, and Sweden | 2004 | 43,120 | Primary CNS tumors: 100% |
79 | Adah S. Zhang [91] | USA | 2017 | 294,666 | Brain tumor: 49.9% (glioblastoma: 44.3%, pilocytic astrocytomas: 3.7%) |
80 | C A STILLER [92] | UK | 1994 | 12,509 | Primary CNS tumors: 100% |